My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
GlycoMimetics (GLYC)
NASDAQ:GLYC

GlycoMimetics Stock Investors

Based on 524,349 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GLYC
On average, investors allocate 3.01% of their portfolios to GLYC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 524,349 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GLYC

4.2%
Last 7
Days
>0.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GLYC, out of 524,349 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GLYC Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
0.00%
$1.91
Closed
0.00%
$1.93
Closed
0.00%
$2.02
Closed
0.00%
$2.25
Based on the activity of 44,124 investors who made their portfolios public
The table shows changes in GLYC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GLYC Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ALNAAllena Pharmaceuticals
5.91%
-0.80%
0.86%
$52.71M
Healthcare
ATNMActinium Pharmaceuticals
6.62%
-2.07%
-4.42%
$139.90M
Healthcare
OBSVObsEva SA
6.52%
-0.73%
-6.43%
$158.28M
Healthcare
AGTCApplied Genetic Technologies
6.11%
-0.02%
20.79%
$84.87M
Healthcare
GTHXG1 Therapeutics
7.99%
0.21%
4.67%
$462.22M
Healthcare
MBIOMustang Bio
3.98%
0.83%
2.62%
$181.25M
Healthcare
PHASPhasebio Pharmaceuticals
2.35%
-1.54%
0.97%
$96.18M
Healthcare
KPTIKaryopharm Therapeutics
3.02%
-1.09%
13.05%
$507.68M
Healthcare
GLMDGalmed Pharmaceuticals
4.02%
-0.81%
0.20%
$48.14M
Healthcare
PTNPalatin Technologies
6.43%
-2.24%
1.49%
$121.57M
Healthcare
Based on the activity of 524,349 active portfolios
Open your Smart Portfolio

GLYC Investor Analysis

GLYC investors under 35

Under 35

39.2%
Last 30 days
Holdings Change
23.3%
of GLYC holders
are under 35
Average Segment Performance
Monthly Return0.56%
Beta1.47
Dividend Yield7.47%
GLYC investors between 35–55

Between 35–55

5.9%
Last 30 days
Holdings Change
63.3%
of GLYC holders
are between 35–55
Average Segment Performance
Monthly Return0.85%
Beta15.42
Dividend Yield30.09%
GLYC investors over 55

Over 55

0.3%
Last 30 days
Holdings Change
13.3%
of GLYC holders
are over 55
Average Segment Performance
Monthly Return0.96%
Beta1.28
Dividend Yield7.58%
Overview of age group and performance of GLYC stock investors
See who invests in GLYC according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
MCURFMind Cure Health
ENTBFEntheon Biomedical
INNPFInnoCan Pharma
BTTXMountain Crest Acquisition II
DNAGinkgo Bioworks Holdings

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis